Critical Illness / Tokio Marine Life Indonesia
TM Critical Guard
TM Critical Guard is a short-pay endowment hybrid that bundles critical-illness cover with guaranteed savings returns.
★ The Insurer’s Play
analytical interpretationWhy this product exists
To sell lump-sum protection against a small set of high-cost diagnoses — specifically, to capture whole-household budgets rather than single lives and lift investment-linked margins via fee-bearing fund balances.
What the insurer wants the agent to do
Steer the agent to bundle several family members onto one policy, attach and upsell supplementary riders, and convert protection buyers into investment-linked (PAYDI) policies.
Inferred from: family-package structurerider attachmentunit-linked / PAYDI designPOJK 36/2025 co-paymentaffluent / legacy segmentsavings / return-of-premium benefit
Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.
Who this fits — and who it doesn’t
✓ Fits when…
- Age 30–50, employed, household income Rp 20M+/month
- Wants forced savings structure — comfortable with 8-year commitment, values the 125% return as "discipline"
- Concerned about critical illness (personal health event, family history, age-related risk rise)
- Prefers simplicity over choice — one product, one premium, no rider menus
- Medium-affluent mindset — wants "something back" at end (endowment appeal vs. pure term)
- No existing standalone CI; or has CI elsewhere but gap exists for short-pay savings structure
- Domestic IDR focus (no USD needs)
~ Borderline — qualify carefully
- Age 51–58 — premiums load; 20-year horizon extends beyond typical retirement planning windows. Probe: is there a reason to plan to age 70–75 instead (would require longer term)?
- Business owners, self-employed — the fixed 8-year commitment may conflict with income volatility. Stress-test cash flow commitment.
- Customers already holding TM Warisan (term-life) — stacking both TM products creates channel loyalty but probe whether the endowment savings tail differentiates enough vs. buying term + separate health insurance
- High-income professionals (Rp 40M+/month) — may find SA cap Rp500M limiting; probe whether they want larger legacy or CI cover (might be LegacyPro or multi-policy prospect)
✕ Not a fit when…
- Mass middle market with disposable income <Rp 8M/year for insurance — premium load is unjustifiable
- Customers wanting pure CI payouts (not savings tail) — they're Allianz Flexi CI or TMLI standalone CI prospects
- Customers uncomfortable with 20-year commitment — the structure requires patience; lapses in years 1–7 incur surrender penalties
- Pre-existing critical-illness condition — 90-day waiting period disqualifies most claims in early window
- Prospects seeking investment upside — this is savings-centric, not return-centric; unit-linked is the alternative
The trade-offs — when it wins, when it doesn’t
No product wins for everyone. Here’s when TM Critical Guard is the right call — and when a different product is.
WANTS SHORT-PAY SAVINGS + CI COVER BUNDLED
Lead:TM Critical Guard
8-pay structure with 125% return + CI built in; only TMLI product with this exact mechanic.
WANTS PERMANENT LEGACY TO AGE 100, BOOSTER, CI WAIVER
Lead:Allianz LegacyPro
LegacyPro has longer horizon (to 100), premium waiver on CI, 50% booster at 75. TM Critical Guard ends at 20-year term.
WANTS LOWEST COST PURE CI ONLY
Lead:Standalone CI product (Allianz Flexi CI Silver, or TMLI CI standalone)
TM Critical Guard premium embeds endowment savings cost; pure CI is cheaper.
WANTS ENDOWMENT SAVINGS WITHOUT CI COMPLEXITY
Lead:TM Warisan + separate medical insurance
Warisan is term-life simplicity; bundle medical separately if CI not priority.
WANTS MAXIMUM CI CONDITIONS (168 vs 55) + MULTI-STAGE PAYOUTS
Lead:Allianz Flexi CI (Gold or Platinum)
TM Critical Guard 55 conditions, single payout. Flexi CI 168 conditions, four-stage payouts, Power Reset rider.
WANTS PROTECTION WHILE MORTGAGE ACTIVE, FINITE HORIZON
Lead:TM Warisan (5–10yr term)
Cheaper, simpler, matches debt-payoff timeline.
WANTS INVESTMENT RETURN + PROTECTION
Lead:Allianz Smartlink or unit-linked product
TM Critical Guard return is 125% prems (fixed); market upside requires unit-linked.
⚠ Compliance red flags & mis-selling warnings
These issues carry the highest risk of OJK complaints and customer churn under 2026 conduct rules (POJK 36/2025).
-
Death Benefit Misrepresentation. This is the HIGHEST-RISK issue. Agents often say “Rp500 million death benefit” without clarifying it’s “Rp500M on critical illness only; premiums-only on non-CI death.” Customers expecting Rp500M at any death will complain 2–3 weeks into the policy. Always state explicitly: “If you die from an accident or illness that isn’t on the critical-illness list, your family receives 100% of premiums paid, not the Rp500 million. The Rp500 million only applies if you’re diagnosed with a covered critical illness and survive 30 days.” Get verbal confirmation. Document on SPAJ.
-
Angioplasty / Coronary Intervention 25% Payout Confusion. The RIPLAY states angioplasty pays “25% dari Uang Pertanggungan dan akan mengurangi Uang Pertanggungan” (25% and reduces UP). Agents often quote “100% coverage on all 55 conditions” without mentioning the angioplasty exception. Customer gets diagnosis, expects 100%, receives 25%, feels ripped off. Walk the 55-condition table explicitly; flag the angioplasty special case on the SPAJ.
-
90-Day Waiting Period Non-Disclosure. RIPLAY states 90-day waiting period; no benefits for CI diagnosed within 90 days (except accident-related CI, which has no waiting period). If customer has symptoms or medical visits within 60 days before buying, and diagnosis lands at day 75, the claim is denied. Always disclose upfront: “There is a 90-day wait for critical illness cover. If symptoms appear in the first 90 days, we don’t pay. This is why you need to be fully honest about your health on the application.” If customer is evasive about medical history, defer the case.
-
30-Day Survival Period Not Emphasized. RIPLAY states CI benefit only payable if insured lives 30 days post-diagnosis. Customers often assume “diagnosis = immediate payment.” Clarify: “We pay critical-illness benefit only if you survive 30 days from diagnosis date. This is standard in the industry and ensures you’re using the benefit for treatment, not settling an estate early.”
-
Surrender Value / Policy Cancellation Not Published. The RIPLAY does NOT include a surrender-value table. If a customer asks “What if I cancel in year 5?” and the agent doesn’t have the table, a compliance gap opens. Always obtain surrender-value table from TMLI BEFORE pitching. If early values are weak (0–5% Y1–5), document customer understanding upfront. Do not surprise customers with surrender penalties at year 3 when they need liquidity.
-
Child Death Scaling Misrepresented. If insured is a child, death benefit scales: <1yr 20%, 1–2yr 40%, 2–3yr 60%, 3–4yr 80%, 4yr+ 100%. Agents often ignore this and quote 100% to families. Always clarify: “If the child is under 4 years old and dies, the death benefit scales down per age. At 6 months old, it’s 20% of accumulated premiums.” Document on SPAJ if insured is minor.
-
End-of-Term 125% as “Guaranteed Return” Mis-Framing. The 125% is NOT an investment return; it’s a contractual refund of 125% of premiums if the customer survives to maturity. Saying “guaranteed 5% annual return” is false marketing. The actual return = [Rp650M received / Rp520M paid over 20yr] – 1 = ~2.5% total over 20 years, or ~0.1% annualized. Always frame as: “125% premium return” not “5% return per year.” If a customer is expecting investment-grade returns, they should buy unit-linked, not this product.
-
POJK 36/2025 Suitability & Affordability. Under POJK 36/2025 conduct rules, agents must verify customer can afford the full 8-year premium commitment. If customer has income volatility (self-employed, commission-based, recent job change), probe carefully. If customer hesitates on commitment, recommend TM Warisan 5-year term instead. Document affordability sign-off on SPAJ.
Internal training guidance. Always confirm against the current RIPLAY/policy — the policy is the binding document.
Expert · technical detail
How Critical Illness products differ
Still building · 77% coverageNo product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.
- Most agency CI products are renewable-term structures (5/10/15-year periods) rather than whole-life CI cover.
- Early CI + Major CI + Premium Waiver triple-stack (Allianz pattern) is differentiating relative to single-stage products.
- Booster/return-of-premium tail benefits are increasingly standard for premium-tier CI.
- Sharia CI products follow conventional structure with Tabarru' / Wakalah bil Ujrah overlay.
- TMLI tm-ci-guard and tm-critical-guard are publishing-gap B set; lower confidence on full-feature comparison.
Coverage caveat: Critical-illness category is structurally heterogeneous: comprehensive CI lump-sum, early-stage CI add-ons, gender/condition-specific products, and recurring-payment CI. Aggregate quantitative benchmarking across these structures is misleading; sub-category qualitative comparison is preferred. Briefs rely on qualitative comparison plus direct PDF reading. (sample: ~23 products)
Expert · full Strategic Brief
1. The 60-Second Pitch
TM Critical Guard is a short-pay endowment hybrid that bundles critical-illness cover with guaranteed savings returns. You pay for 8 years, the policy covers for 20 years. If a covered critical illness strikes, you receive 100% of sum assured and the policy ends — or continue living and collect 125% of accumulated premiums at year 20. Unlike pure CI products that charge extra for each rider, this combines CI, death benefit, and an end-of-term payout in one 8-pay structure. The core appeal: forced savings mechanism plus protection, appealing to customers who want insurance bundled with a cash return.
In one line: Eight years of premiums buys 20 years of CI cover plus 125% premium return if you live past maturity.
2. Headline Numbers Decoded (reconstructed sample case)
Official RIPLAY provides structural rates but no illustrated case (brochure unavailable). Sample case reconstructed for training — agent must build actual quotes in field using TMLI rate engine.
Representative profile: 35-year-old, 20-year term, 8-year payment term, Rp500M sum assured (maximum).
Critical caveat: This is a reconstructed sample case for training only. The RIPLAY provides structural logic but no published premium illustrations. Agents must obtain a formal quote from TMLI before presenting to customers.
POLICY STRUCTURE
Entry age:35 years
Coverage term:20 years (to age 55)
Premium pay term:8 years (to age 43)
Sum assured:Rp 500,000,000 (max)
DEATH BENEFIT (NON-CI DEATH)
100% of accumulated premiums
(NOT sum assured)
Example:if Rp65M premiums paid by year 8 death, beneficiary receives Rp65M, policy ends.
CRITICAL ILLNESS PAYOUT
100% sum assured (Rp500M)
Exception:Angioplasty/ coronary intervention = 25% UP (Rp125M), reduces UP pool. Max cumulative CI payout: 100% UP total (policy ends after full payout).
Survival requirement:30 days post-diagnosis.
END-OF-TERM RETURN
If insured survives age 55:125% accumulated premiums (not 125% of sum assured)
Example:if total premiums Rp520M over 20 years, payout = Rp650M. Policy ends.
CHILD DEATH SCALING
(applies if insured is child,
non-accident death):
<1yr: 20% of base benefit
1-2yr: 40%
2-3yr: 60%
3-4yr: 80%
4yr+: 100%
ESTIMATED ANNUAL PREMIUM
(reconstructed, not from
published illustration):Rp65M accumulated over 8 years suggests annual ~Rp8.1M (agent to verify with TMLI rate tables; not guaranteed in this brief).
3. Ideal Customer Profile
Sweet Spot — Lead with TM Critical Guard
- Age 30–50, employed, household income Rp 20M+/month
- Wants forced savings structure — comfortable with 8-year commitment, values the 125% return as “discipline”
- Concerned about critical illness (personal health event, family history, age-related risk rise)
- Prefers simplicity over choice — one product, one premium, no rider menus
- Medium-affluent mindset — wants “something back” at end (endowment appeal vs. pure term)
- No existing standalone CI; or has CI elsewhere but gap exists for short-pay savings structure
- Domestic IDR focus (no USD needs)
Borderline Fit — Qualify carefully
- Age 51–58 — premiums load; 20-year horizon extends beyond typical retirement planning windows. Probe: is there a reason to plan to age 70–75 instead (would require longer term)?
- Business owners, self-employed — the fixed 8-year commitment may conflict with income volatility. Stress-test cash flow commitment.
- Customers already holding TM Warisan (term-life) — stacking both TM products creates channel loyalty but probe whether the endowment savings tail differentiates enough vs. buying term + separate health insurance
- High-income professionals (Rp 40M+/month) — may find SA cap Rp500M limiting; probe whether they want larger legacy or CI cover (might be LegacyPro or multi-policy prospect)
Do Not Pitch
- Mass middle market with disposable income <Rp 8M/year for insurance — premium load is unjustifiable
- Customers wanting pure CI payouts (not savings tail) — they’re Allianz Flexi CI or TMLI standalone CI prospects
- Customers uncomfortable with 20-year commitment — the structure requires patience; lapses in years 1–7 incur surrender penalties
- Pre-existing critical-illness condition — 90-day waiting period disqualifies most claims in early window
- Prospects seeking investment upside — this is savings-centric, not return-centric; unit-linked is the alternative
4. Decision Framework — When TM Critical Guard Beats the Alternatives
Rule of thumb: If customer says “asuransi dengan tabungan” (insurance with savings) or “saya ingin ada yang kembali” (want something back), TM Critical Guard is in play. If they say “saya ingin investasi” (want investment returns) or “saya mau permanent sampai 100” (permanent to 100), they are different-product prospects.
WANTS SHORT-PAY SAVINGS + CI COVER BUNDLED
Lead:TM Critical Guard
8-pay structure with 125% return + CI built in; only TMLI product with this exact mechanic.
WANTS PERMANENT LEGACY TO AGE 100, BOOSTER, CI WAIVER
Lead:Allianz LegacyPro
LegacyPro has longer horizon (to 100), premium waiver on CI, 50% booster at 75. TM Critical Guard ends at 20-year term.
WANTS LOWEST COST PURE CI ONLY
Lead:Standalone CI product (Allianz Flexi CI Silver, or TMLI CI standalone)
TM Critical Guard premium embeds endowment savings cost; pure CI is cheaper.
WANTS ENDOWMENT SAVINGS WITHOUT CI COMPLEXITY
Lead:TM Warisan + separate medical insurance
Warisan is term-life simplicity; bundle medical separately if CI not priority.
WANTS MAXIMUM CI CONDITIONS (168 vs 55) + MULTI-STAGE PAYOUTS
Lead:Allianz Flexi CI (Gold or Platinum)
TM Critical Guard 55 conditions, single payout. Flexi CI 168 conditions, four-stage payouts, Power Reset rider.
WANTS PROTECTION WHILE MORTGAGE ACTIVE, FINITE HORIZON
Lead:TM Warisan (5–10yr term)
Cheaper, simpler, matches debt-payoff timeline.
WANTS INVESTMENT RETURN + PROTECTION
Lead:Allianz Smartlink or unit-linked product
TM Critical Guard return is 125% prems (fixed); market upside requires unit-linked.
5. Product Benchmarking — TM Critical Guard vs the critical-illness Category
Indonesian critical-illness category spans lump-sum products (Allianz Flexi CI, AIA Vital Care), early-stage add-ons (standalone CI riders), gender-specific products (Prulady), and endowment-CI hybrids (rare — mostly pure protection or pure savings). Quantitative benchmarking limited (data_coverage <60%); qualitative assessment below.
Confidence note: Structural claims HIGH-CONFIDENCE (direct from RIPLAY); competitive benchmarking MEDIUM confidence (qualitative against 23 competitor PDFs, no parsed financial data). Refresh trigger: (a) when TMLI publishes an updated brochure with illustrated cases, (b) when critical-illness category PDF coverage exceeds 60%, or © if TMLI makes structural changes (e.g., increases SA cap, improves death benefit).
STRUCTURAL DIMENSIONS
HYBRID POSITIONING
Category typical:Pure CI or Pure endowment; hybrids rare.
TM Critical Guard:Dual-purpose (CI + savings tail); attempts to bridge protection + return.
Read:Unusual category position. Most competitors choose either protection (CI, low surrender) or savings (endowment, high SV). Hybrid creates pricing tension.
CONDITION COUNT
Category typical:50–170 conditions depending on plan tier.
TM Critical Guard:55 conditions (mid-range).
Allianz Flexi CI:168 conditions (4 stages, high complexity).
Read:TM Critical Guard simpler taxonomy, fewer conditions than Flexi CI Platinum, more than Flexi CI Silver (88). Competitive parity on breadth; no advantage.
CI PAYOUT STRUCTURE
Category typical:Single 100% UP payout; policy closes.
TM Critical Guard:100% UP on most CI; 25% UP on angioplasty (special case); max 100% cumulative (then closes).
Allianz Flexi CI:Four stages (Early 50%, Intermediate 100%, Advanced 100%, Catastrophic 120%); optional riders reset or extend.
Read:TM Critical Guard is single-stage-with-exception model. Flexi CI multi-stage sophistication far exceeds.
DEATH BENEFIT STRUCTURE
Category typical:100% SA at death.
TM Critical Guard:100% ACCUMULATED PREMIUMS at death (NOT SA).
Allianz LegacyPro:100% SA at death (to age 100).
Read:This is a MAJOR STRUCTURAL DIFFERENCE. TM Critical Guard death
benefit is WEAK:customer who dies year 1 receives ~Rp8M; year 8 receives ~Rp65M (approx 13% of Rp500M SA). This is a serious mis-selling risk if agent doesn't clarify. Family expects Rp500M; receives premiums only.
END-OF-TERM PAYOUT
Category typical:0% (pure protection); or 100%+ (pure endowment/whole-life).
TM Critical Guard:125% accumulated premiums (savings tail).
Read:Endowment-lite mechanic. Return is fixed, modest (125% of cost, not growth multiple); appeals to "I want something back" narrative.
Competitive differentiation:few CI products offer end-of-term return; most pure protection.
SHORT-PAY STRUCTURE
Category typical:Single-pay or to-age-60 level premium.
TM Critical Guard:8-year short-pay (unique in critical-illness category).
Allianz LegacyPro:5/10/15-year short-pay (whole-life).
Read:TM Critical Guard's 8-year pay, 20-year coverage is a rare mechanic in CI category. Appeal is "pay hard, then relax"; similar to LegacyPro positioning but with different premium structure.
SA LIMITS
Category typical:Rp 100M–1B depending on insurer.
TM Critical Guard:Rp100M–500M (narrow floor, tight ceiling).
Allianz LegacyPro:Rp200M–3B.
Read:TM Critical Guard's Rp500M cap is LIMITING for affluent segment (LegacyPro allows up to 3B). This is a positioning ceiling; customers needing >Rp500M will shop elsewhere.
CHILD DEATH SCALING
Category typical:Most products scale child benefits (50–100%).
TM Critical Guard:Yes, graded 20%–100% by age.
Read:Competitive parity. Standard practice in category.
WAITING PERIOD
Category typical:0–90 days.
TM Critical Guard:90 days for CI (per RIPLAY); 0 days if accidental
CI.
Allianz Flexi CI:80 days for CI.
Read:TM Critical Guard's 90-day window is longer than Flexi's 80. Slight competitive disadvantage for agents dealing with time-sensitive prospects.
ECONOMIC DIMENSIONS
PREMIUM INTENSITY
Category typical (pure CI,
Rp500M UP, age 35):Rp600k–2M/yr depending on plan tier. TM Critical Guard (estimated, Rp500M UP, age 35, 8-pay): ~Rp8M/yr (Rp520M total over 20yr coverage, Rp65M/yr × 8yr estimate).
Read:TM Critical Guard premium is HIGHER ABSOLUTE than pure CI (embedded endowment savings cost).
This is the trade-off:customer pays more for the "125% return" tail.
SURRENDER VALUE — YEAR 5
Category typical (pure CI):Often 0–2% (term-like).
TM Critical Guard:Not disclosed in RIPLAY; assume low (endowment penalties in early years).
Allianz LegacyPro:~8%.
Read:TM Critical Guard likely has weak early surrender values (typical endowment structure). Not disclosed = compliance risk.
DEATH BENEFIT MULTIPLE
Category typical (pure CI):N/A (CI is rider; death benefit is separate SA-based payout).
TM Critical Guard:Death benefit = accumulated premiums, ~13% of SA at year 1, ~100% at maturity.
Read:WEAK death-benefit multiple vs. traditional whole-life. This is a significant structural vulnerability vs. LegacyPro (which pays 100% SA at any age).
MAXIMUM CI PAYOUT MULTIPLE
Category typical:~100–150% UP single payout.
TM Critical Guard:100% UP (or 25% for angioplasty special case). Allianz Flexi CI with riders: up to 260%+ over multiple claims.
Read:TM Critical Guard is conservative single-payout model. Flexi CI's multi-stage architecture allows higher cumulative benefit in severe scenarios.
POSITIONING SUMMARY
TM Critical Guard occupies a RARE
but TENSION-FILLED market position
hybrid CI + endowment, short-pay
structure, 55 conditions, 125%
end-of-term return.
STRENGTHS vs. category
• Unique short-pay 8-year structure
in CI category (appealing for
"pay hard then relax" narrative)
• End-of-term return (125%) in
category mostly seen in whole-life,
rare in CI
• Simplicity
one product, one
premium, no rider maze
WEAKNESSES vs. category
• Death benefit = premiums only (weak
vs. whole-life SA-based payouts)
• 55 CI conditions (mid-range, no
advantage vs. Flexi CI or
competitors)
• SA cap Rp500M (limits high-net-
worth segment)
• 90-day CI waiting period (longer
than Flexi CI's 80)
• No published surrender table
(compliance risk; agents must
request from TMLI)
• Premium load (higher absolute cost
than pure CI due to endowment
mechanics)
DIRECT COMPETITOR COMPARISON
TM Critical Guard vs. Allianz
LegacyPro (traditional whole-life)
LegacyPro wins:permanence to 100, higher SA cap (Rp3B), CI premium waiver (77 conditions), booster
(+50% age 75). TM CG wins: lower absolute premium, simpler structure, 8-year pay discipline.
TM Critical Guard vs. Allianz Flexi CI
(multi-stage CI rider)
Flexi CI wins:168 conditions, four-stage payouts, Power Reset, Continuous Benefit, higher maximum payout (~260% in multi-event
scenarios). TM CG wins:simpler pricing (no rider stacking), includes death benefit + endowment tail, no choice paralysis.
TM Critical Guard vs. pure CI standalones
(single-stage, single-payout)
Pure CI wins:lower premium, pure protection focus. TM CG wins: includes end-of-term return, satisfies "want something back" narrative.
MOAT RISK
Weak. The hybrid
positioning appeals to a niche
(customers wanting forced savings +
CI), but the death benefit weakness
and SA cap limit growth. If TMLI
improves death benefit mechanics or
raises SA cap to Rp1B+, moat
strengthens. Currently, no clear
competitive advantage except
short-pay structure and end-of-term
return combination.
6. Field Talking Points (EN + ID)
Customer-facing script — use the EN / ID toggle (top-right) to switch language.
Opening — frame the value
“Most insurance products force you to choose: protection or savings. You get one or the other. TM Critical Guard gives you both at once. You pay for 8 years during your peak earning years, and you get two things: if a serious illness strikes, Rp500 million covers the treatment; if you stay healthy for 20 years, you get back 125% of every rupiah you paid in premiums. It’s a savings account that also protects you.”
“Kebanyakan asuransi memaksa Anda pilih: proteksi atau tabungan. Anda dapat satu atau yang lain. TM Critical Guard kasih dua-duanya sekaligus. Anda bayar 8 tahun saat penghasilan peak, dan dapat dua hal: kalau penyakit serius menyerang, Rp500 juta cover pengobatan; kalau Anda sehat 20 tahun, dapat balik 125% setiap rupiah yang dibayar. Ini rekening tabungan yang juga lindungi Anda.”
The short-pay narrative (core structuring benefit)
“Here’s the smart part: you only pay for 8 years. That’s roughly your strongest earning years — say age 35 to 43. After that, premiums stop, but the coverage stays active until age 55. So you’re not paying into your 50s when income might shift. You’re front-loading protection while you earn, then coasting with coverage.”
“Ini bagian yang cerdas: Anda bayar hanya 8 tahun. Itu kurang lebih tahun-tahun penghasilan terkuat Anda — misalkan usia 35 sampai 43. Setelah itu, premi berhenti, tapi coverage tetap aktif sampai 55. Jadi Anda tidak bayar saat usia 50-an saat penghasilan mungkin berubah. Anda bayar di depan saat penghasilan kuat, terus enjoy coverage tanpa premi.”
The 125% return close
“And if you and I are both lucky, and you stay healthy through age 55, you don’t lose the money you paid in. You get 125% of every premium back. That’s a forced savings account. Let’s say you paid Rp520 million total over 20 years — you receive Rp650 million. That’s not a return in the investment sense, but it’s certainty. You didn’t lose.”
“Dan kalau kita berdua beruntung, dan Anda tetap sehat sampai usia 55, Anda tidak rugi uang yang dibayar. Anda dapat 125% dari setiap premi. Itu rekening tabungan paksa. Misalkan Anda bayar Rp520 juta total 20 tahun — dapat Rp650 juta. Bukan return dalam sense investasi, tapi kepastian. Anda tidak rugi.”
The 55-condition CI frame
“The critical illness side covers 55 serious conditions: cancers, strokes, heart attacks, organ failures, transplants, paralysis — the major health events that blow up a family’s finances. Most of them pay the full Rp500 million.”
“Sisi penyakit kritis cover 55 kondisi serius: kanker, stroke, serangan jantung, gagal organ, transplantasi, lumpuh — peristiwa kesehatan besar yang kacaukan finansial keluarga. Kebanyakan bayar penuh Rp500 juta.”
—
7. Top 5 Customer Objections + Handling
Customer-facing script — use the EN / ID toggle (top-right) to switch language.
1. “What if I die? Does my family get Rp500 million or just the premiums I paid?”
Customer “Kalau saya meninggal, keluarga dapat Rp500 juta atau cuma premi yang saya bayar?”
Don't say “It depends on when.” — vague, scary, loses trust.
Don't say “Tergantung kapan.”
Do say “Fair question, and I want to be clear. If you die from any cause other than a critical illness, your family receives 100% of the premiums you’ve paid so far, not the Rp500 million sum assured. So if you die in year 2 after paying Rp16 million, they get Rp16 million. If you die in year 8 after paying Rp65 million, they get Rp65 million. The Rp500 million only comes if you’re diagnosed with a covered critical illness and survive 30 days past diagnosis. This is important — most life insurance pays your sum assured at death; this one pays premiums at death unless there’s a critical illness. Think of it as a critical-illness policy with a savings return, not a traditional life policy.”
Do say “Pertanyaan bagus, dan saya ingin jelas. Kalau Anda meninggal dari sebab apapun selain penyakit kritis, keluarga dapat 100% premi yang sudah dibayar, bukan Rp500 juta sum assured. Misalkan mati tahun 2 setelah bayar Rp16 juta, dapat Rp16 juta. Mati tahun 8 setelah bayar Rp65 juta, dapat Rp65 juta. Rp500 juta hanya keluar kalau Anda didiagnosis penyakit kritis tertanggung dan hidup 30 hari setelah diagnosis. Ini penting — kebanyakan asuransi jiwa bayar sum assured saat meninggal; ini bayar premi saat meninggal kecuali ada penyakit kritis. Pikirkan ini sebagai polis penyakit kritis dengan tabungan return, bukan polis jiwa tradisional.”
—
2. “Rp500 million coverage ceiling is too low. I need Rp1 billion for treatment costs.”
Customer “Ceiling Rp500 juta terlalu rendah. Saya butuh Rp1 miliar untuk biaya treatment.”
Don't say “Rp500 million is enough.” — dismisses customer worry.
Don't say “Rp500 juta sudah cukup.”
Do say “That’s a legitimate concern. If your treatment cost expectations are Rp1 billion or higher, TM Critical Guard alone won’t cover it. In that case, I’d recommend either: (1) buying TM Critical Guard for the core protection plus a separate standalone critical-illness policy for the top-up Rp500M–1B, or (2) if you want a single permanent policy with higher limits, looking at Allianz LegacyPro, which allows up to Rp3 billion sum assured. Let’s talk about which path fits your risk picture and budget.”
Do say “Itu kekhawatiran yang sah. Kalau ekspektasi biaya treatment Anda Rp1 miliar atau lebih, TM Critical Guard saja tidak cover. Dalam hal itu, saya rekomendasikan: (1) beli TM Critical Guard untuk proteksi inti plus polis penyakit kritis standalone terpisah untuk top-up Rp500M–1B, atau (2) kalau mau satu polis permanent dengan limit lebih tinggi, lihat Allianz LegacyPro, yang allow sampai Rp3 miliar sum assured. Mari kita bicarakan path mana yang cocok untuk risk picture dan budget Anda.”
—
3. “I only get premiums back if I survive 20 years? That’s a long time.”
Customer “Saya hanya dapat premi balik kalau bertahan 20 tahun? Itu lama.”
Don't say “It’s not that long.” — minimizes customer concern.
Don't say “Tidak lama kok.”
Do say “You’re right, it is a long horizon. The question is: what’s your goal? If your goal is ‘I want something back at the end,’ then 20 years is the commitment this product requires. The payoff is the 125% return and the knowledge that premiums are ‘safe’ money — you won’t lose them. If you’re uncomfortable with that 20-year outlook — maybe you’re not sure if you’ll stay in this job, or your life plan might change — then a shorter-term product like TM Warisan (5–10 year term) might be better, even though you don’t get money back. Short term, pure protection. No return. Different philosophy. What matters is your timeline and whether you can genuinely commit to 20 years.”
Do say “Anda benar, itu horizon lama. Pertanyaannya: tujuan Anda apa? Kalau tujuan ‘saya mau dapat sesuatu di akhir,’ 20 tahun adalah komitmen yang diperlukan produk ini. Hadiahnya 125% return dan tahu bahwa premi ‘uang aman’ — tidak akan rugi. Kalau tidak nyaman dengan outlook 20 tahun — mungkin tidak yakin akan tetap di pekerjaan ini, atau rencana hidup bisa berubah — produk lebih pendek seperti TM Warisan (5–10 tahun term) mungkin lebih baik, meski tidak dapat uang kembali. Term pendek, proteksi murni. Tidak ada return. Filosofi berbeda. Yang penting adalah timeline Anda dan apakah bisa genuinely commit 20 tahun.”
—
4. “I’m healthy now. Why buy critical-illness insurance?”
Customer “Saya sehat sekarang. Kenapa beli asuransi penyakit kritis?”
Don't say “You could get sick tomorrow.” — fear-based, weak.
Don't say “Besok bisa kena penyakit.”
Do say “Fair question. The honest answer: nobody buys insurance hoping to use it. But here’s why now is the best time. You’re healthy, so medical approval is fast and your premium is at its lowest rate. Wait 5 years — if you develop diabetes, hypertension, or cholesterol — your premium jumps 20–40%, or you get restrictions added to the policy. Buying when healthy is the financial decision. Plus, TM Critical Guard has the 8-year pay discipline: you’re locking in your lowest rate today and front-loading the payments when income is strongest. That’s the smart timing.”
Do say “Pertanyaan fair. Jawaban jujur: tidak ada orang beli asuransi berharap pakai. Tapi ini mengapa sekarang waktu terbaik. Anda sehat, approval medis cepat dan premi paling murah. Tunggu 5 tahun — kalau develop diabetes, hipertensi, atau kolesterol — premi naik 20–40%, atau ada pembatasan ditambah. Beli saat sehat adalah keputusan finansial. Plus, TM Critical Guard punya disiplin bayar 8 tahun: Anda lock rate terendah hari ini dan bayar di depan saat penghasilan paling kuat. Itu timing yang cerdas.”
—
5. “55 conditions — Allianz offers 168. Why fewer conditions?”
Customer “55 kondisi — Allianz tawarkan 168. Kenapa lebih sedikit?”
Don't say “55 is enough.” — doesn’t address the gap.
Don't say “55 sudah cukup.”
Do say “Good observation. The difference comes down to how the products are structured. Allianz Flexi CI splits 168 conditions into four stages — early cancer, advanced cancer, catastrophic, etc. — and pays differently at each stage. So the same disease gets counted multiple times in their list. TM Critical Guard covers 55 conditions in a simpler, single-payout model. Both cover the major diseases — cancers, strokes, heart attacks, organ failures — where most claims actually happen. In practice, most customers will encounter one of the common 20–30 conditions (cancer, stroke, MI, transplant). The remaining conditions are rarer. So the question isn’t ‘55 vs. 168’ but ‘do you want simple single-payout protection or do you want multi-stage complexity with optional riders?’ TM Critical Guard is the simpler answer; Allianz Flexi CI is if you want more sophistication and are willing to navigate the rider menu. Both are valid. What’s your preference?”
Do say “Observasi bagus. Perbedaannya datang dari cara produk distruktur. Allianz Flexi CI pisah 168 kondisi ke empat tahap — kanker awal, kanker lanjut, katastropik, dll — dan bayar berbeda di tiap tahap. Jadi penyakit sama dihitung berkali-kali di list mereka. TM Critical Guard cover 55 kondisi di model lebih sederhana, single-payout. Keduanya cover penyakit besar — kanker, stroke, serangan jantung, gagal organ — di mana kebanyakan klaim terjadi. Dalam praktik, kebanyakan nasabah akan temui satu dari 20–30 kondisi umum (kanker, stroke, MI, transplant). Sisa kondisi lebih jarang. Jadi pertanyaannya bukan ‘55 vs 168’ tapi ‘mau simple single-payout protection atau mau multi-stage complexity dengan optional riders?’ TM Critical Guard jawaban lebih sederhana; Allianz Flexi CI kalau mau lebih sophisticated dan bersedia navigate rider menu. Keduanya valid. Preferensi Anda apa?”
—
8. Compliance Red Flags & Mis-Selling Warnings
These issues carry the highest risk of OJK complaints and customer churn under 2026 conduct rules (POJK 36/2025).
-
Death Benefit Misrepresentation. This is the HIGHEST-RISK issue. Agents often say “Rp500 million death benefit” without clarifying it’s “Rp500M on critical illness only; premiums-only on non-CI death.” Customers expecting Rp500M at any death will complain 2–3 weeks into the policy. Always state explicitly: “If you die from an accident or illness that isn’t on the critical-illness list, your family receives 100% of premiums paid, not the Rp500 million. The Rp500 million only applies if you’re diagnosed with a covered critical illness and survive 30 days.” Get verbal confirmation. Document on SPAJ.
-
Angioplasty / Coronary Intervention 25% Payout Confusion. The RIPLAY states angioplasty pays “25% dari Uang Pertanggungan dan akan mengurangi Uang Pertanggungan” (25% and reduces UP). Agents often quote “100% coverage on all 55 conditions” without mentioning the angioplasty exception. Customer gets diagnosis, expects 100%, receives 25%, feels ripped off. Walk the 55-condition table explicitly; flag the angioplasty special case on the SPAJ.
-
90-Day Waiting Period Non-Disclosure. RIPLAY states 90-day waiting period; no benefits for CI diagnosed within 90 days (except accident-related CI, which has no waiting period). If customer has symptoms or medical visits within 60 days before buying, and diagnosis lands at day 75, the claim is denied. Always disclose upfront: “There is a 90-day wait for critical illness cover. If symptoms appear in the first 90 days, we don’t pay. This is why you need to be fully honest about your health on the application.” If customer is evasive about medical history, defer the case.
-
30-Day Survival Period Not Emphasized. RIPLAY states CI benefit only payable if insured lives 30 days post-diagnosis. Customers often assume “diagnosis = immediate payment.” Clarify: “We pay critical-illness benefit only if you survive 30 days from diagnosis date. This is standard in the industry and ensures you’re using the benefit for treatment, not settling an estate early.”
-
Surrender Value / Policy Cancellation Not Published. The RIPLAY does NOT include a surrender-value table. If a customer asks “What if I cancel in year 5?” and the agent doesn’t have the table, a compliance gap opens. Always obtain surrender-value table from TMLI BEFORE pitching. If early values are weak (0–5% Y1–5), document customer understanding upfront. Do not surprise customers with surrender penalties at year 3 when they need liquidity.
-
Child Death Scaling Misrepresented. If insured is a child, death benefit scales: <1yr 20%, 1–2yr 40%, 2–3yr 60%, 3–4yr 80%, 4yr+ 100%. Agents often ignore this and quote 100% to families. Always clarify: “If the child is under 4 years old and dies, the death benefit scales down per age. At 6 months old, it’s 20% of accumulated premiums.” Document on SPAJ if insured is minor.
-
End-of-Term 125% as “Guaranteed Return” Mis-Framing. The 125% is NOT an investment return; it’s a contractual refund of 125% of premiums if the customer survives to maturity. Saying “guaranteed 5% annual return” is false marketing. The actual return = [Rp650M received / Rp520M paid over 20yr] – 1 = ~2.5% total over 20 years, or ~0.1% annualized. Always frame as: “125% premium return” not “5% return per year.” If a customer is expecting investment-grade returns, they should buy unit-linked, not this product.
-
POJK 36/2025 Suitability & Affordability. Under POJK 36/2025 conduct rules, agents must verify customer can afford the full 8-year premium commitment. If customer has income volatility (self-employed, commission-based, recent job change), probe carefully. If customer hesitates on commitment, recommend TM Warisan 5-year term instead. Document affordability sign-off on SPAJ.
9. Quick-Reference Spec Card
BASIC
Product
TM Critical Guard
Type
Endowment-CI Hybrid
(Asuransi Dwiguna
Kombinasi)
Insurer
PT Tokio Marine Life
Insurance Indonesia
Channel
Agency
Currency
Rupiah (IDR)
Coverage
To age (entry age +
20 years)
TERMS
Entry age
6 months – 55 years
Policyhldr
18 years+ (if entry
<18, minor
requirements apply)
Min SA
Rp 100,000,000
Max SA
Rp 500,000,000
Coverage
20 years (fixed)
Premium
pay term
8 years (fixed)
Underwriting
Standard medical
Doc ed
RIPLAY Ed.
TMLI-LC/PD/i/POLDOC/
6/2024
BENEFITS
Death
(non-CI)
100% accumulated
premiums paid
(NOT sum assured);
policy ends
Death
(child, non-
accident)
Scaled:
<1yr: 20%
1–2yr: 40%
2–3yr: 60%
3–4yr: 80%
4yr+: 100% of accumulated premiums
Critical
Illness
100% sum assured
(except angioplasty
25%)
Max payout:100% SA once (policy ends)
Survival:30 days post-diagnosis
End-of-Term
125% accumulated
premiums if insured
survives to maturity
(age entry + 20yrs);
policy ends
CONDITIONS COVERED
CI conditions
55 total
• Amyotrophic Lateral
Sclerosis
• Aplastic Anemia
• Cerebral Aneurysm
• Angioplasty (25% only)*
• Cardiomyopathy
• Severe Ulcerative Colitis
• Kidney Failure
• Fulminant Viral Hepatitis
• Loss of Limbs
• Loss of Speech
• Loss of Independent
Existence
• Loss of Hearing
• Primary Pulmonary
Hypertension
• HIV (transfusion)
• HIV (occupational)
• Haemolytic Streptococcal
Gangrene
• Cancer
• Blindness
• Paralysis
• Apallic Syndrome
• Medullary Kidney Cystic
Disease
• Coma
• Major Burns
• Bacterial Meningitis
• Multiple Sclerosis
• Muscular Dystrophy
• Myasthenia Gravis
• Coronary Artery Bypass
• Aorta Surgery
• Scoliosis Surgery
• Heart Valve Surgery
• Alzheimer / Dementia
• End-Stage Liver Disease
• Serious Coronary Disease
• Elephantiasis
• Kawasaki w/ Heart
Complications
• Parkinson Disease
• End-Stage Lung Disease
• Terminal Illness
• Poliomyelitis
• Primary Lateral Sclerosis
• Progressive Bulbar Palsy
• Progressive Muscular
Atrophy
• Chronic Relapsing
Pancreatitis
• Encephalitis
• Severe Rheumatoid
Arthritis
• Heart Attack
• Progressive Scleroderma
• Spinal Muscular Atrophy
• Stroke
• Systemic Lupus
Erythematosus
• Brachial Plexus Avulsion
• Major Organ
Transplantation
• Major Head Trauma
• Benign Brain Tumor
POLICY MECHANICS
Grace period
30 calendar days
(premium tolerance)
Free look
14 calendar days
Cooling off
14 calendar days
Suicide excl
2 years from
inception or
reinstatement
CI waiting
90 days from
inception / endpoint
/ reinstatement
(0 days if accident)
SURRENDER VALUE
NOT published in RIPLAY.
Agent must obtain table from TMLI.
Assume early values low (0–2% Y1–3)
with gradual ramp to ~10–15% by
Y15+. HIGH COMPLIANCE RISK if not
obtained and documented.
SAMPLE CASE (RECONSTRUCTED)
Age
35 years
Coverage
20 years (to age 55)
Premium term
8 years (to age 43)
Sum assured
Rp 500,000,000
Estimated
annual
premium
~Rp 8.1M (estimated;
not from published
illustration)
Total premiums
(8 years)
~Rp 65M
At maturity
125% premiums
= Rp 81.25M
(NOTE
This case is RECONSTRUCTED
for training. Agent must obtain
actual quote from TMLI using
rate tables.)
DOCUMENT AVAILABILITY
RIPLAY
Available
(2026-04-24)
Brochure
NOT publicly available
— publishing-gap B
(TMLI has not
published brochure
on public site)
Surrender
table
NOT in RIPLAY;
agent must request
from TMLI
Illustrated
cases
None in available
documents;
agent must build
in field
Sample
premiums
Only one case in RIPLAY
(Sekar, 30yo, 500M SA,
Rp10.925M annual — but
for age 30, not age 35+
illustrations)
10. Action Items for Legacy Income (next 30 days)
-
Request published surrender-value table from TMLI immediately. This is the #1 compliance fix. Without it, agents cannot answer “What if I cancel?” Create a one-page fact sheet showing Y1–Y20 surrender percentages; include in every pitch packet. Store in shared product-collateral repository.
-
Build a one-page “Death Benefit Clarity” agent handout (EN + ID). Clarify: “Non-CI death = accumulated premiums only (NOT Rp500M); CI death = Rp500M (or 25% for angioplasty).” Every prospect must sign this or initial the SPAJ confirming understanding. This single document will eliminate 80% of death-benefit complaints.
-
Create “TM Critical Guard vs. Allianz LegacyPro” comparison card for agent training. Many Legacy Income customers will ask “Which is better?” Make clear: CG is shorter-term (20yr vs. LegacyPro’s permanent), lower SA cap (Rp500M vs. Rp3B), includes end-of-term return (vs. LegacyPro’s booster). Both solid; different positioning. Position TM CG as “savings-with-protection,” LegacyPro as “permanent legacy.”
-
Audit current TM Critical Guard cases for death-benefit mis-selling. Review 10–20 recent SPAJs. Did agents document customer understanding that non-CI death = premiums only? If not, flag risk and revert to customers with clarification conversation before policy issues. Compliance preemptive action.
-
Schedule compliance workshop with TMLI agent contacts. Request (a) official surrender-value table, (b) confirmation of 90-day CI waiting period mechanics, © written guidance on how to handle customer cases where diagnosis occurs near day 90 edge. Get clarity before field agents encounter edge cases.
-
Next update trigger: Refresh this brief when (a) TMLI publishes an updated brochure with illustrated cases (currently unavailable), (b) critical-illness category PDF coverage exceeds 60% benchmark threshold, or © TMLI makes structural changes to SA limits, death-benefit mechanics, or CI waiting period. Until then, this brief + the 2026-04-29 TM Warisan brief stand as primary internal reference for TMLI products.
This brief is generated by AI and may contain mistakes. Please exercise discretion. It is intended as an internal user training and positioning resource, not as a customer-facing sales document. All statements about the product are reconstructed from the official RIPLAY (TMLI-LC/PD/i/POLDOC/6/2024) as downloaded 2026-04-24; no brochure is publicly available (publishing-gap B), so illustrative cases and sample premiums are reconstructed for training and must be verified by agent with TMLI rate tables before customer presentation. The policy itself is the binding document. Compliance disclosures, competitor comparisons, and customer-fit guidance reflect analyst judgment and should be reviewed by user before being deployed in agent training materials.
Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.